Trailhead Biosystems Inc.

About Trailhead Biosystems Inc.

Trailhead Biosystems is a biotech company focused on pioneering precision in cellular differentiation using their High-Dimensional Design-of-Experiments (HD-DoE) platform. They aim to revolutionize cellular research for drug discovery and cell-based therapies, advancing regenerative medicine and personalized healthcare.

Products & Services

TrailBio(r) Hematopoietic Progenitor Cells:Suitable for differentiation into multiple blood lineages, ideal for disease modeling, drug discovery, and toxicology studies.

TrailBio(r) A9 Dopaminergic Neurons:Specialized midbrain neurons crucial for motor control, important for studying Parkinson's disease and neurodegeneration.

TrailBio(r) Vascular Leptomeningeal Cells:Cells for research applications (specific details not provided in content).

Custom iPSC Differentiation:Service for tailored induced pluripotent stem cell differentiation.

New Cell Development:Service focused on developing new cell types for research and therapeutic applications.

Therapeutic Partnerships:Collaborations for therapeutic development using their cell technologies.

TrailBio® Endothelial Cells

TrailBio® Hematopoietic Progenitor Cells

TrailBio® Vascular Leptomeningeal Cells

TrailBio® A9 Dopaminergic Neurons

Specialties

Cellular Differentiation High-Dimensional Design-of-Experiments (HD-DoE) Regenerative Medicine Personalized Healthcare Drug Discovery Cell-Based Therapies iPSC-derived human cells HD-DoE® platform Custom iPSC differentiation Vascular biology research Blood-brain barrier studies

Funding History

Debug: View Raw Funding Data

#	Type	Amount Fields	Date Fields	Investors
1	RT: Expansion Financing T: - FT: Expansion Financing	A: 40000000 MR: - FA: $40 million FAN: 40000000	D: 2026-01-12 FD: 2026-01-12	1 investors
2	RT: Financing T: - FT: Financing	A: 20000000 MR: - FA: $20 million FAN: 20000000	D: 2025-05-06 FD: 2025-05-06	1 investors

Expansion Financing Latest

2026-01-12

$40.0M

1 investor (Pro only)

Financing 2025-05-06

$20.0M

View 1 more funding rounds with Pro

Unlock Full Funding History

Growth Metrics

+45%

Employee Growth

YoY

3.2x

Funding Growth

Last Round

12

Markets

Operating

10K+

Customers

Active

View 3 more growth metrics with Pro

Unlock All Metrics

Mock Up

Team & Leadership

D

David Llewellyn

President and Chief Executive Officer

D

Div Trivedi

Chief Operating Officer

J

Josh Snow

Chief Commercial Officer

J

Jennifer Antonchuk

VP Research & Development

M

Michael Kaufman

Chief Executive Officer, MAK Capital

C

Craig Nemiroff

Managing Director, MAK Capital

View 6 more team members with Pro

Unlock Full Team Directory

Recent News